Finnegan Beats Humira IP Licensing Claims for AbbVie

Finnegan Beats Humira IP Licensing Claims for AbbVie

Jan Wolfe

A U.K. arthritis research trust overreached by demanding more patent royalties from drugmaker and longtime licensee AbbVie, an appeals court ruled on Thursday.

      LOAD MORE